Angiodynamics (ANGO) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $76.3 million.
- Angiodynamics' Total Non-Current Liabilities fell 1790.08% to $76.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $76.3 million, marking a year-over-year decrease of 1790.08%. This contributed to the annual value of $80.3 million for FY2025, which is 1639.15% down from last year.
- Angiodynamics' Total Non-Current Liabilities amounted to $76.3 million in Q4 2025, which was down 1790.08% from $72.6 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Total Non-Current Liabilities ranged from a high of $149.8 million in Q2 2023 and a low of $61.7 million during Q3 2023
- Its 5-year average for Total Non-Current Liabilities is $101.9 million, with a median of $96.4 million in 2022.
- Within the past 5 years, the most significant YoY rise in Angiodynamics' Total Non-Current Liabilities was 4058.81% (2023), while the steepest drop was 5440.76% (2023).
- Over the past 5 years, Angiodynamics' Total Non-Current Liabilities (Quarter) stood at $105.2 million in 2021, then surged by 34.21% to $141.2 million in 2022, then plummeted by 32.15% to $95.8 million in 2023, then fell by 2.99% to $92.9 million in 2024, then fell by 17.9% to $76.3 million in 2025.
- Its Total Non-Current Liabilities was $76.3 million in Q4 2025, compared to $72.6 million in Q3 2025 and $80.3 million in Q2 2025.